Ads
related to: circulating tumor cell test- For Health Systems
Elevate Patient First Healthcare
Innovative Multi-Cancer Detection
- Manage Population Health
Groundbreaking Cancer Test Tech
Explore Health System Partnership
- For Health Systems
Search results
Natera to present new cancer test data at ASCO meeting By Investing.com
Investing.com· 2 days agoAmong the presentations, notable data from the CIRCULATE-Japan GALAXY study will be shared,...
Plant Virus Fights Cancers in Mice With 'Widespread Effectiveness'
ScienceAlert via Yahoo News· 5 days agoAs before, mice given nanoparticles from the cowpea mosaic virus fared significantly better than...
Rutgers Cancer Institute and RWJBarnabas Health Set to Unveil Extensive, New Cancer Research...
FOX 4 Kansas City· 2 days agoClinicians and scientists from Rutgers Cancer Institute and RWJBarnabas Health will lead sessions...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 2 days agoSALT LAKE CITY, May 23, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, and its collaborators will share data from seven studies at the 2024 ASCO Annual Meeting. Three studies
Urine Tests Could Be 'Enormous Step' in Diagnosing Cancer
Medscape· 5 days agoThe next frontier in cancer detection could be the humble urine test. Emerging science suggests that...
Rutgers Cancer Institute and RWJBarnabas Health Se | Newswise
Newswise· 3 days agoClinicians and scientists from Rutgers Cancer Institute and RWJBarnabas Health will lead sessions...
Biomed 2024 Showcases Israel’s Resilient Entrepreneurial Spirit
Forbes· 6 days agoThe need to defend Israeli citizens on multiple fronts for more than seven months has not depressed...
MD Anderson Research Highlights: ASCO 2024 Special | Newswise
Newswise· 3 days agoThe University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These
Blueprint Medicines to Present the First Promising and Most Advanced Clinical Data for a CDK2...
WJTV Jackson· 2 days agoBlueprint Medicines Corporation (Nasdaq: BPMC) today announced updated data from the ongoing Phase 1 dose escalation portion of the VELA clinical trial of BLU-222, an investigational, highly ...